KIT and metastatic melanoma: This was observed in human cultured melanoma cells [56] and in cutaneous melanomas (from radial growth phase to vertical growth phase and metastatic melanoma) [57], which led to the hypothesis that the loss of KIT could represent a negative prognostic factor [56,57].